|
1
|
Zhang XG: Risk factors and prevention
research progress of esophagus cancer. World Chin J Dig.
17:670–680. 2009.(In Chinese).
|
|
2
|
Li XK and Fan QX: The research progress of
esophageal cancer drug therapy. World Chin J Dig. 35:3482–3487.
2012.(In Chinese).
|
|
3
|
Kelsen D, Ajani J, Ilson D, Daugherty K
and Pazdur R: A phase ii trial of paclitaxel (Taxol) in advanced
esophageal cancer: Preliminary report. Semin Oncol. 5:(Suppl 8).
44–48. 1994.
|
|
4
|
Li LQ: The geographical distribution of
buttercup family of Trollius chinensis. Acta Phytotaxonomica
Sinica. 33:535–537. 1995.(In Chinese).
|
|
5
|
Li YL, Ye SM, Wang LY and Cen YZ:
Isolation and biological activity of proglobeflowery acid from
Trollius chinensis Bunge. J Jinan Univ. 23:124–126. 2002.(In
Chinese).
|
|
6
|
Shen ZP: Traditional Chinese medicine
pharmaceutical research and application of Trollius
chinensis. Lishizhen Med Mater Med Res. 11:1110–1113. 2000.(In
Chinese).
|
|
7
|
Su LJ, Tian H and Ma YL: Trollius
chinensis Bunge ethanol-extraction objects in experimental
study of antiviral effect. Chin Herb Med. 38:1062–1064. 2007.(In
Chinese).
|
|
8
|
Sun L, Liu F, Liu H, Luo Q and An F: The
effects of Trolliusflavonoids on human breast cancer cells.
J Chin G. 29:1098–1099. 2009.(In Chinese).
|
|
9
|
Sun L, Cheng JZ, Luo Q, Zhang XC, Bai XM
and An F: Effects of Trollius flavonoids on proliferation of
K562, HeLa, Ec-109 and NCI-H446 tumor cells. Med J Zhengzhou Univ.
44:981–983. 2009.(In Chinese).
|
|
10
|
Sun L, Luo Q, Zhang L, Hao XQ, Liu H, Tian
JM and An F: Effects of Trollius flavonoids on growth and apoptosis
of A549 cells. J Chin G. 31:82–83. 2011.(In Chinese).
|
|
11
|
Su LJ, Wang H and Su ZW: Chemical
component and pharmacology of Trollius. World Notes Plant
Med. 20:14–16. 2005.(In Chinese).
|
|
12
|
Kang SW and Yu YF: The research on
Trollius chemical component. Chin Herb Med. 15:7–9. 1984.(In
Chinese).
|
|
13
|
Liu LJ, Wang XK and Kuang HX: Study on the
chemical composition of leaves and stalks of Trollius
macropetalus. Yao Xue Xue Bao. 27:837–840. 1992.(In Chinese).
PubMed/NCBI
|
|
14
|
Fu XC, Li SP, Wang XG and Yan Z: Research
on antithrombotic effect of orientin. China Pharm. 17:1292–1293.
2006.(In Chinese).
|
|
15
|
Yang GD, Rao N and Tian JM: The study on
antioxidant effect of orientin and vitexin from Trollius
chinensis. Lishizhen Med Mater Med Res. 22:2172–2173. 2011.(In
Chinese).
|
|
16
|
Fu XC, Wang X and Zheng H: The protective
effect of orientin on ischemic and anoxic myocardial cells. J Sou
Med Univ. 127:1173–1175. 2007.(In Chinese).
|
|
17
|
Yang GD, Rao N, Tian JM, An F and Wang SH:
Study on antioxidation of orientin and vitexin from Trollius
chinensis. Lishizhen Med Mater Med Res. 22:2172–2173. 2011.(In
Chinese).
|
|
18
|
Zhang X: Research progress of vitexin
pharmacologic action. China Med Hed. 10:35–42. 2013.(In
Chinese).
|
|
19
|
Chang W: The structure-activity
relationship and ROS related mechanism of anti-cancer effect of
flavonoids. Chongqing: TMMU; 2008, (In Chinese).
|
|
20
|
Wu XA, Qin F and Du MQ: Quantitative
structure and anti- inflammatory activity relationship preliminary
discussion of flavone-C glycosides. Lishizhen Med Mater Med Res.
23:632–633. 2012.(In Chinese).
|
|
21
|
Wu XA, Qing F and Du MQ: The QSAR study on
anti-inflammatory activities of C-glycosy flavones. Lishizhen Med
Mater Med Res. 23:632–633. 2012.(In Chinese).
|
|
22
|
Lamm GM, Steinlein P, Cotten M and
Christofori G: A rapid, quantitative and inexpensive method for
detecting apoptosis by flow cytometry in transiently transfected
cells. Nucleic Acids Res. 23:4855–4857. 1997. View Article : Google Scholar
|
|
23
|
Lu W: The mechansim of shikonin-induced
apoptosis in MCF-7 breast cancer. Jilin Univ. 17–23. 2013.(In
Chinese).
|
|
24
|
Peng L, Qi FL and Yin YH: New approach of
oncotherapy - Chinese medicine ingredients induced differentiation
of malignant cell. B Bio. 37:8–11. 2002.(In Chinese).
|
|
25
|
EI-Aneed A: Current strategies in cancer
gene therapy. Eur J Pharm. 498:1–8. 2004. View Article : Google Scholar
|
